These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
137 related articles for article (PubMed ID: 2934788)
21. Aztreonam in gram-negative infections in children. Sklavunu-Tsurutsoglu S; Gatzola-Karaveli M; Hitoglu-Makedu A; Paradelis AG; Tsurutsoglu G Chemioterapia; 1987 Jun; 6(2 Suppl):415-7. PubMed ID: 3509461 [No Abstract] [Full Text] [Related]
22. The use of aztreonam in serious gram-negative infections. Smith G; Bunney RG; Farrell ID; Wood MJ J Antimicrob Chemother; 1988 Feb; 21(2):233-41. PubMed ID: 3283094 [TBL] [Abstract][Full Text] [Related]
23. Aztreonam therapy for complicated urinary tract infections caused by multidrug-resistant bacteria. Cox CE Rev Infect Dis; 1985; 7 Suppl 4():S767-71. PubMed ID: 3909335 [TBL] [Abstract][Full Text] [Related]
24. Evaluation of aztreonam in the treatment of severe bacterial infections. Romero-Vivas J; Rodríguez-Créixems M; Bouza E; Hellín T; Guerrero A; Martínez-Beltrán J; García de la Torre M Antimicrob Agents Chemother; 1985 Aug; 28(2):222-6. PubMed ID: 3834832 [TBL] [Abstract][Full Text] [Related]
25. Efficacy and safety of aztreonam in the treatment of serious gram-negative bacterial infections. LeFrock JL; Smith BR; Chandrasekar P; Rolston KV; Molavi A; Kannangara W Arch Intern Med; 1987 Feb; 147(2):325-8. PubMed ID: 3813751 [TBL] [Abstract][Full Text] [Related]
26. The use of aztreonam in pediatric patients: a review. Bosso JA; Black PG Pharmacotherapy; 1991; 11(1):20-5. PubMed ID: 1902290 [TBL] [Abstract][Full Text] [Related]
27. The role of aztreonam in treatment of complicated urinary tract infections in children. Kline MW Pediatr Infect Dis J; 1989 Sep; 8(9 Suppl):S113-6; discussion S128-32. PubMed ID: 2682509 [TBL] [Abstract][Full Text] [Related]
28. Aztreonam. Cunha BA Urology; 1993 Mar; 41(3):249-58. PubMed ID: 8442309 [TBL] [Abstract][Full Text] [Related]
29. The clinical use of aztreonam. Schönwald S; Schoss-Vidensek Z; Car V; Krznar B Chemotherapy; 1989; 35 Suppl 1():45-8. PubMed ID: 2731450 [TBL] [Abstract][Full Text] [Related]
36. Aztreonam in the treatment of aerobic, gram-negative bacillary infections in pediatric patients. Trujillo H; Harry N; Arango A; Benítez G; Restrepo F; Mejía GI; Castrillón AL Chemotherapy; 1989; 35 Suppl 1():25-30. PubMed ID: 2731447 [TBL] [Abstract][Full Text] [Related]
37. Comparison of aztreonam and tobramycin in the treatment of lower respiratory tract infections caused by gram-negative bacilli. Nolen TM; Phillips HL; Hall HJ Rev Infect Dis; 1985; 7 Suppl 4():S666-8. PubMed ID: 3909321 [TBL] [Abstract][Full Text] [Related]
38. Gram-negative bacillary pneumonia in the nosocomial setting. Role of aztreonam therapy. Cook JL Am J Med; 1990 Mar; 88(3C):34S-37S; discussion 38S-42S. PubMed ID: 2316557 [TBL] [Abstract][Full Text] [Related]
39. Efficacy and safety of aztreonam in the treatment of patients with renal failure. Sion ML; Pyrpasopoulos M; Nicolaidis P; Papagianni C; Tsurutsoglu G Rev Infect Dis; 1991; 13 Suppl 7():S652-4. PubMed ID: 2068477 [TBL] [Abstract][Full Text] [Related]